Kabir Kumar Nath
Chief Executive Officer at COMPASS PATHWAYS PLC
Net worth: 77 405 $ as of 2024-04-29
Network origin in Kabir Kumar Nath first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 22 | |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Otsuka Canada Pharmaceutical, Inc.
 Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kabir Kumar Nath via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
COMPASS Pathfinder Holdings Ltd.
 COMPASS Pathfinder Holdings Ltd. Financial ConglomeratesFinance Part of Compass Pathways Plc, COMPASS Pathfinder Holdings Ltd. is an investment holding British company. The company is based in London, UK and was founded in 2017. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Masters Business Admin Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel Private Equity Investor | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| Rochester Christian University | College/University | Undergraduate Degree Doctorate Degree | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
Compass Pathfinder Ltd.
 Compass Pathfinder Ltd. BiotechnologyHealth Technology Part of Compass Pathways Plc, Compass Pathfinder Ltd. engages in research and experimental development on biotechnology. The company is based in Altrincham, UK. | Biotechnology | Director/Board Member Director/Board Member | |
| DIMENSION THERAPEUTICS INC | Biotechnology | Director/Board Member Chief Executive Officer | |
American Foundation for Suicide Prevention
 American Foundation for Suicide Prevention Miscellaneous Commercial ServicesCommercial Services The American Foundation for Suicide Prevention is a non-profit organization dedicated to saving lives and providing hope to those affected by suicide. The company is based in New York, NY, with a public policy office in Washington, D.C. The organization has local chapters in all 50 states and offers programs and events nationwide. AFSP creates a culture that is knowledgeable about mental health through education and community programs, advocates for suicide prevention through research and public policy, and provides support for those affected by suicide. If you are concerned that someone may be considering suicide, the AFSP provides resources and guidance on how to talk to someone who may be struggling with their mental health. The CEO of the company is Robert Gebbia. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
CellMedical SA
 CellMedical SA Medical/Nursing ServicesHealth Services CellMedical SA operates medical diagnostic laboratories. The company is headquartered in Thessaloniki, Greece. | Medical/Nursing Services | Chairman | |
PlaqueTec Ltd.
 PlaqueTec Ltd. Miscellaneous Commercial ServicesCommercial Services PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
Oncimmune Ltd.
 Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Biotechnology | Director/Board Member | |
| The European Commission | General Government | Corporate Officer/Principal | |
| London School of Hygiene & Tropical Medicine | College/University | Corporate Officer/Principal | |
| SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Chairman | |
AOBiome Therapeutics, Inc.
 AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| AFFIMED N.V. | Biotechnology | Director/Board Member | |
Genomics England Ltd.
 Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| Phaim Pharma Ltd. | Director/Board Member | ||
The Conduit Connect Ltd.
 The Conduit Connect Ltd. Internet Software/ServicesTechnology Services The Conduit Connect Ltd. is a private membership platform for high net worth, sophisticated, and professional impact investors. The company is based in London, UK. The British company connects founders who are building scalable, for-profit, impact-driven businesses to capital and expert resources. The company source and connects the most promising high growth impact investing opportunities to mission-aligned investors. The company was founded in 2018, and the CEO is Eva-Maria Dimitriadis. | Internet Software/Services | Chairman | |
| FasterCures | Director/Board Member | ||
Perspectum Ltd.
 Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom. | Medical/Nursing Services | Director/Board Member | |
PhESi LLC
 PhESi LLC Pharmaceuticals: MajorHealth Technology PhESi LLC provides drug and clinical development services for life sciences companies. The private company is based in East Lyme. | Pharmaceuticals: Major | Director/Board Member | |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Director/Board Member | |
Perspectum Group Ltd.
 Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Director/Board Member | |
The King's Fund
 The King's Fund Investment Trusts/Mutual FundsMiscellaneous The King's Fund organizes healthcare conferences and other events. The company was founded in 1897 and is headquartered in London, the United Kingdom. | Investment Trusts/Mutual Funds | Director/Board Member | |
Ryse Asset Management LLP
 Ryse Asset Management LLP Investment ManagersFinance RYSE Asset Management LLP (RYSE) is a venture capital firm founded in 2010 by Atique Mirza. The firm is headquartered in London, the United Kingdom. | Investment Managers | Chairman | |
Noxsudor Therapeutics Ltd.
 Noxsudor Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Noxsudor Therapeutics Ltd. manufactures capsules that control sweating. | Pharmaceuticals: Major | Director/Board Member | |
| Secret Saviours Ltd. | Director/Board Member | ||
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
| British Heart Foundation | Miscellaneous Commercial Services | Director/Board Member | |
| SKYE BIOSCIENCE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Biogen Idec Ltd.
 Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Biotechnology | Director/Board Member | |
| AVROBIO, INC. | Biotechnology | Director/Board Member | |
| ONCIMMUNE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Thrombolytic Science International LLC
 Thrombolytic Science International LLC Pharmaceuticals: MajorHealth Technology Thrombolytic Science International LLC operates as a vascular medicine and biotech company. The company was founded by Alexis Wallace and Victor Gurewich and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| Läkemedelsverket | Corporate Officer/Principal | ||
NDA Group AB
 NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
The Medical Products Agency
 The Medical Products Agency Pharmaceuticals: MajorHealth Technology The Medical Products Agency is a government agency based in Uppsala, Sweden. The agency is responsible for promoting public and animal health in Sweden with regards to pharmaceuticals, medical technology, and cosmetics. The agency is also known as the Swedish Medicines Agency and is tasked with ensuring the safety and efficacy of these products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| Pharma Executive Consulting Ltd. | Founder | ||
| ANALYTICA | Medical Specialties | Director/Board Member | |
Global Kinetics Pty Ltd.
 Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia. | Medical Specialties | Director/Board Member | |
| University of Uppsala | College/University | Graduate Degree | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Tech/Sci/R&D Officer |
Statistics
International
| United Kingdom | 22 |
| United States | 18 |
| Sweden | 6 |
| Germany | 3 |
| Australia | 3 |
Sectoral
| Health Technology | 24 |
| Commercial Services | 8 |
| Consumer Services | 5 |
| Finance | 4 |
| Technology Services | 4 |
Operational
| Director/Board Member | 141 |
| Corporate Officer/Principal | 51 |
| Chairman | 42 |
| Independent Dir/Board Member | 37 |
| President | 20 |
Most connected contacts
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Wayne Riley | 34 |
| Donald Hayden | 23 |
| Thomas Insel | 22 |
| Linda McGoldrick | 21 |
| David Norton | 18 |
| Daphne Karydas | 16 |
| Robert McQuade | 14 |
| Ron Newbold | 13 |
| Michael Falvey | 12 |
| George Goldsmith | 12 |
| Thomas Lönngren | 11 |
| Yves Rosconi | 11 |
| Stephen D. Schultz | 10 |
| Trevor Anthony Mill | 10 |
- Stock Market
- Insiders
- Kabir Kumar Nath
- Company connections
